1. Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
- Author
-
Hans-Martin Jaeck, Markus Cornberg, Stella Christoph, Andrea Sauer, Tobias Welte, Edith Roth, Louisa Ruhl, Lennart Boblitz, Jana Keil, Isabell Pink, Julius J. Schmidt, Sascha David, Thomas F. Schulz, Christine S. Falk, Marius M. Hoeper, Jenny F. Kuehne, and K. Beushausen
- Subjects
Chemokine ,biology ,business.industry ,medicine.medical_treatment ,Lymphocyte ,Regeneration (biology) ,medicine.disease ,Endothelial activation ,Cytokine ,medicine.anatomical_structure ,Immune system ,Immunology ,medicine ,biology.protein ,Endothelial dysfunction ,Antibody ,business - Abstract
The systemic processes involved in the manifestation of life-threatening COVID-19 and in disease recovery are still incompletely understood, despite investigations focusing on the dysregulation of immune responses after SARS-CoV-2 infection. To define hallmarks of severe COVID-19 and disease recovery in convalescent patients, we combined analyses of immune cells and cytokine/chemokine networks with endothelial activation and injury. ICU patients displayed an altered immune signature with prolonged lymphopenia but expansion of granulocytes and plasmablasts along with activated and terminally differentiated T and NK cells and high levels of SARS-CoV-2-specific antibodies. Core signature of seven plasma proteins revealed a highly inflammatory microenvironment in addition to endothelial injury in severe COVID-19. Changes within this signature were associated with either disease progression or recovery. In summary, our data suggest that besides a strong inflammatory response, severe COVID-19 is driven by endothelial activation and barrier disruption, whereby recovery depends on the regeneration of the endothelial integrity.
- Published
- 2021
- Full Text
- View/download PDF